Latest News for: rnai

Edit

FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A ...

Business Wire 29 Mar 2025
ALNY), the leading RNAi therapeutics company, today highlighted the significance of the U.S.
Edit

Risk assessment considerations for RNAi‐based genetically modified plants (EFSA - European Food Safety Authority)

Public Technologies 21 Mar 2025
) Risk assessment considerations for RNAi‐based genetically modified plants ... When a GMP is developed to silence transcripts by RNA interference (RNAi), some specific additional analysis needs to be provided by the applicant.
  • 1
×